Register for our free email digests:
Merck & Co. Inc.
www.merck.com
Latest From Merck & Co. Inc.
What Lies Beneath China's Steep Price Cuts For New Drugs
Prices of direct acting hepatitis C drugs are down by 85% in China, with cancer and antidiabetes therapy costs cut by 65% and drug makers are rushing to celebrate. Scrip delves into the considerations behind the low prices and whether industry's excitement is a bit premature.
Lynparza, Keytruda Supplemental Indications Face US FDA Panel Review
AstraZeneca and Merck seek to add a pancreatic cancer indication for olaparib, while Merck has hopes of broadening pembrolizumab’s use in bladder cancer; two-day Oncologic Drugs Advisory Committee meeting also will include reviews of Celgene’s luspatercept in myelodysplastic syndromes-related anemia and Epizyme’s tazemetostat for epithelioid sarcoma.
C-Suite Snippets: Behind The Scenes At Gates Medical Research Institute
In case you missed it: catch up with snippets from interviews recently published by In Vivo.
Big Pharma’s Aging Antibodies Cling To Their Crowns
The best-seller rankings today are testament to the great success of antibody drug technology developed at the end of the last century, and contrast with the dominance of primary care small molecule drugs that powered big pharma in previous decades. But where did these drugs come from – and where are they going?
Company Information
- Industry
-
Pharmaceuticals
- Vaccines
- Therapeutic Areas
- Cardiovascular
- Gynecological, Urological
- Infectious & Viral Diseases
- Inflammation
- Musculoskeletal & Connective Tissue Disorders
- Neurology, Nervous System
- Ophthalmic
- Respiratory, Pulmonary
- Alias(es)
- Ownership
- Public
- Headquarters
-
Worldwide
-
North America
-
USA
-
USA
-
North America
- Company Type
- Big Pharma
- Parent & Subsidiaries
-
Merck & Co. Inc.
- Abello SA
- Abmaxis Inc.
- Afferent Pharmaceuticals Inc.
- American Biodyne
- Assured Health Systems
- Bone Measurement Institute
- BritCair Ltd.
- cCAM Biotherapeutics Ltd.
- Cubist Pharmaceuticals Inc.
- GlycoFi Inc.
- Hangzhou MSD Pharmaceutical Co. Ltd.
- Idenix Pharmaceuticals Inc.
- Inspire Pharmaceuticals Inc.
- IOmet Pharma Ltd.
- Merck BioVentures
- Merck Consumer Healthcare Group
- Merck Frosst Canada Inc.
- Merck Genome Research Institute
- Merck Human Health Division
- Merck Research Laboratories
- Merck Sharp & Dohme Ltd.
- Merck Specialty Chemicals Group
- Merck Vaccine Division
- Merck-Supera Farma JV
- MSD Consumer Care Inc.
- MSD India
- MSD KK
- NovaCardia Inc.
- Oncoethix SA
- Peloton Therapeutics Inc.
- Rigontec GMBH
- Rosetta Inpharmatics LLC
-
Schering-Plough Corp.
- Canji Inc.
- DNAX Research Institute
- Essex Chemie AG
- Integrated Therapeutics Group Inc.
- Key Pharmaceuticals Inc.
- NeoGenesis Pharmaceuticals Inc.
- Organon NV
- Schering Canada
- Schering Corp.
- Schering Laboratories
- Schering-Plough (Brinny) Co.
- Schering-Plough Healthcare Products Inc.
- Schering-Plough Ltd.
- Schering-Plough Pharmaceuticals
- Schering-Plough Research Institute
- Scholl International
- Scholl US Division
- Shanghai Schering-Plough Pharmaceutical Co. Ltd.
- Warrick Pharmaceuticals
- Sibia Neurosciences Inc.
- SmartCells Inc.
- SMSD (Shanghai) Ltd.
- SysteMed Inc.
- Tilos Therapeutics Inc.
- Viralytics Ltd.
- West Point Pharma
- Senior Management
-
Kenneth C Frazier, CEO
Robert M Davis, EVP, CFO - Contact Info
-
Merck & Co. Inc.
Phone: (908) 740-4000
2000 Galloping Hill Rd.
Kenilworth, NJ 07033
USA
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice